Why Test for H. pylori if HDGC Gastric Cancer is Genetic?
At a Glance
Even though HDGC is caused by a genetic mutation, H. pylori is a common bacteria that causes stomach inflammation and increases cancer risk. Doctors treat H. pylori to remove this preventable danger, though it does not replace the need for regular HDGC screening or preventative surgery.
In this answer
3 sections
Even though Hereditary Diffuse Gastric Cancer (HDGC) is caused by an inherited genetic mutation (most commonly in the CDH1 gene), your doctor asks about Helicobacter pylori (H. pylori) because it is a major, preventable risk factor for stomach cancer. Having a genetic predisposition means your baseline risk for stomach cancer is already very high. Your doctor wants to eliminate any additional environmental factors that could further increase that risk or accelerate cancer development. Since H. pylori is a bacterial infection that can be cured with antibiotics, finding and treating it is a simple, effective way to remove an unnecessary danger to your stomach.
Genetic Risk vs. Environmental Risk
To understand why your doctor cares about a bacterium when you have a genetic condition, it helps to look at how cancer develops:
- The Genetic Driver: HDGC is primarily caused by germline (inherited) mutations, most often in the CDH1 gene [1][2]. If you have this mutation, the cells in your stomach are already prone to becoming cancerous. This process can happen entirely independently of H. pylori; people with CDH1 mutations can and do develop stomach cancer without ever being exposed to the bacteria [3].
- The Environmental Danger: H. pylori is a very common bacterium that lives in the stomach lining and causes chronic inflammation. It is a well-established, pro-cancerous factor and is the leading cause of “sporadic” (non-hereditary) stomach cancer worldwide [4].
Why Your Doctor Wants to Eradicate H. pylori
When it comes to managing a high-risk condition like HDGC, your medical team’s goal is to control every variable possible. Here is why testing for and treating H. pylori is standard practice:
- It Prevents “Adding Fuel to the Fire”: Cancer development is often described as requiring “multiple hits” to the body’s cells. While your genetics provide the first hit, chronic inflammation from a bacterial infection acts as an additional stressor. Research indicates that the combination of a rare CDH1 mutation alongside an active H. pylori infection may contribute to an increased risk of aggressive gastric cancer [5].
- It Is Completely Modifiable: Currently, there is no way to fix the underlying genetic mutation causing HDGC. Managing the genetic risk requires intense endoscopic surveillance or a prophylactic (preventative) gastrectomy [1]. However, H. pylori is highly treatable. Eliminating the bacteria is a widely recognized and recommended strategy to reduce the incidence of stomach cancer [6][7]. By treating it, your doctor is simply removing a known carcinogen from an already vulnerable environment [8].
- It Protects You During Surveillance: If you are postponing a prophylactic gastrectomy and relying on regular endoscopic surveillance, keeping your stomach lining free of H. pylori inflammation makes it healthier and buys you the safest time possible. (If your surgery is already scheduled for the very near future, talk to your doctor about whether treating the infection first is still necessary).
What to Expect
If your doctor wants to check for H. pylori, they will typically use a breath test, a stool test, or take a small tissue sample (biopsy) during your routine surveillance endoscopy.
If you test positive, you will likely be prescribed a combination of antibiotics and acid-reducing medications to clear the infection.
- The Treatment Course: This regimen usually requires taking multiple pills a day for 10 to 14 days. It is a heavy course of antibiotics that can cause temporary stomach upset, so it helps to be mentally prepared.
- Re-testing: Once you finish the medication, your doctor will re-test you to ensure the bacteria is completely gone. This “test of cure” must happen at least 4 weeks after finishing your antibiotics (and often 1-2 weeks after stopping acid reducers) to avoid a false negative result.
- Family Testing: Because H. pylori can spread among people living in the same household, your doctor might recommend testing close family members as well—especially since they might share your CDH1 mutation.
Important Note: Eradicating H. pylori does not cure HDGC, lower your genetic risk, or eliminate the need for HDGC-specific screening and surgery [9]. It simply removes an extra, preventable risk factor from the equation.
Common questions in this guide
Why does my doctor care about H. pylori if my stomach cancer risk is genetic?
Will treating an H. pylori infection prevent hereditary diffuse gastric cancer?
Should my family members be tested for H. pylori if I test positive?
How is an H. pylori infection treated?
Can treating H. pylori delay my prophylactic gastrectomy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How soon should I be tested for H. pylori, and which test do you recommend?
- 2.If I test positive, how will the antibiotic treatment affect my upcoming endoscopy or gastrectomy schedule?
- 3.Since H. pylori can spread in households, should my family members be tested, especially those who share my CDH1 mutation?
- 4.What side effects should I expect from the antibiotic regimen, and how can I manage them while protecting my stomach?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (9)
- 1
Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A Review.
Gamble LA, Heller T, Davis JL
JAMA surgery 2021; (156(4)):387-392 doi:10.1001/jamasurg.2020.6155.
PMID: 33404644 - 2
Surveillance and Surgical Considerations in Hereditary Diffuse Gastric Cancer.
Gamble LA, Davis JL
Gastrointestinal endoscopy clinics of North America 2022; (32(1)):163-175 doi:10.1016/j.giec.2021.08.009.
PMID: 34798984 - 3
Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.
Funakoshi T, Miyamoto S, Kakiuchi N, et al.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2019; (22(4)):892-898 doi:10.1007/s10120-018-00912-w.
PMID: 30542785 - 4
Host pathogen interactions in Helicobacter pylori related gastric cancer.
Chmiela M, Karwowska Z, Gonciarz W, et al.
World journal of gastroenterology 2017; (23(9)):1521-1540 doi:10.3748/wjg.v23.i9.1521.
PMID: 28321154 - 5
Genomically Silent Refractory Gastric Cancer in a Young Patient Exhibits Overexpression of CXCL5.
Hernandez J, Turner MA, Bali P, et al.
Current oncology (Toronto, Ont.) 2022; (29(7)):4725-4733 doi:10.3390/curroncol29070375.
PMID: 35877235 - 6
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
Lee YC, Chiang TH, Chou CK, et al.
Gastroenterology 2016; (150(5)):1113-1124.e5 doi:10.1053/j.gastro.2016.01.028.
PMID: 26836587 - 7
Helicobacter pylori infection prevalence declined among an urban health check-up population in Chengdu, China: a longitudinal analysis of multiple cross-sectional studies.
Zou JC, Wen MY, Huang Y, et al.
Frontiers in public health 2023; (11()):1128765 doi:10.3389/fpubh.2023.1128765.
PMID: 38089026 - 8
Prevalence of the cagA Virulence Factor Varies by Race Among Helicobacter pylori -Infected Patients Undergoing Upper Endoscopy.
Epplein M, McCall SJ, Wang F, et al.
Clinical and translational gastroenterology 2024; (15(6)):e1 doi:10.14309/ctg.0000000000000713.
PMID: 38742743 - 9
Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in CDH1 Mutation Carriers.
Ithurralde-Argerich J, Rosner L, Rizzolo M, et al.
Journal of laparoendoscopic & advanced surgical techniques. Part A 2021; (31(7)):729-737 doi:10.1089/lap.2021.0239.
PMID: 34097461
This page explains the relationship between HDGC and H. pylori for educational purposes. It does not replace professional medical advice from your gastroenterologist or oncologist.
Get notified when new evidence is published on Hereditary diffuse gastric cancer.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.